Matthew Smith
MD, PhD
Director, Genitourinary Malignancies Program
👥Biography 个人简介
Matthew Smith is a prostate cancer specialist at Massachusetts General Hospital whose research has defined PSA doubling time as a critical biomarker for risk stratification in non-metastatic CRPC. He led the pivotal DENOSUMAB 147 study demonstrating bone metastasis prevention in high-risk nmCRPC. His work spans hormonal therapy consequences including bone loss, metabolic effects, and cardiovascular risk in prostate cancer patients. Smith has made foundational contributions to understanding skeletal complications of prostate cancer therapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Matthew Smith 的研究动态
Follow Matthew Smith's research updates
留下邮箱，当我们发布与 Matthew Smith（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment